Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
A Conservative MP has denied favouriting an explicit pornographic image on Twitter.
Police forces in North, South and West Yorkshire, Humberside and Lincolnshire have been told they require improvement, in a new HMIC report
ITV Calendar's Political Correspondent Paul Brand reflects on his meeting with UKIP's biggest donor, Paul Sykes.